AMTI
Closed
Applied Molecular Transport inc
0.263
0.000 (0.00%)
Last Update: 29 Dec 2023 17:30:00
Yesterday: 0.263
Day's Range: 0.263 - 0.263
Send
sign up or login to leave a comment!
When Written:
0.32
Applied Molecular Transport Inc (AMT) is a clinical-stage biopharmaceutical company that develops oral biologic therapies to treat autoimmune diseases, inflammatory bowel disease (IBD), and other diseases. AMT's proprietary technology platform, known as the AMT-101 platform, uses a novel approach to deliver biologic drugs to the gut, where they can be absorbed and distributed throughout the body. This approach has the potential to improve the efficacy and safety of biologic drugs, which are currently administered via injections or infusions. AMT is based in South San Francisco, California, and was founded in 2016. The company went public in 2020 and is listed on the NASDAQ exchange under the ticker symbol AMTI.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








